Clincosm LogoSign in Get a demo

Hormone Receptor Positive Breast Carcinoma

Showing 1 - 17 of 17
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor, Advanced Breast Cancer, Metastatic Breast Cancer Trial (BGB-43395, Fulvestrant, Letrozole)

Not yet recruiting
  • Advanced Solid Tumor
  • +8 more
  • (no location specified)
Nov 13, 2023

CLEAR-B: Cancer Landscape - Early Adjuvant Retrospective

Recruiting
  • Breast Cancer
  • +2 more
    • Erlangen, Germany
      Department of Gynecology and Obstetrics, Erlangen University Hos
    May 12, 2023

    Hormone Receptor Positive Breast Carcinoma, Breast Tumors, Tumors, Breast Trial in Italy (Liquid biopsy and CT scan)

    Recruiting
    • Hormone Receptor Positive Breast Carcinoma
    • +6 more
    • Liquid biopsy and CT scan
    • Bergame, Bergamo, Italy
    • +6 more
    Apr 13, 2023

    Breast Cancer, Metastatic Breast Cancer, Hormone Receptor Positive Breast Carcinoma Trial in Washington, Baltimore, Hackensack

    Active, not recruiting
    • Breast Cancer
    • +2 more
    • Washington, District of Columbia
    • +4 more
    Jan 31, 2023

    Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

    Suspended
    • Anatomic Stage I Breast Cancer AJCC v8
    • +23 more
    • Short-Term Fasting
    • Chemotherapy
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Jan 23, 2023

    Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Triple Negative Breast Cancer Trial in United States

    Recruiting
    • Non Small Cell Lung Cancer
    • +11 more
    • Denver, Colorado
    • +3 more
    Jan 10, 2023

    Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in Duarte

    Recruiting
    • Anatomic Stage IV Breast Cancer AJCC v8
    • +3 more
    • Duarte, California
      City of Hope Medical Center
    Nov 1, 2022

    Breast Cancer, Hormone Receptor Positive Breast Carcinoma Trial in Badalona, Sant Cugat Del Vallès, Barcelona (Elacestrant)

    Completed
    • Breast Cancer
    • Hormone Receptor Positive Breast Carcinoma
    • Badalona, Barcelona, Spain
    • +3 more
    Oct 25, 2022

    Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United

    Recruiting
    • Anatomic Stage IV Breast Cancer AJCC v8
    • +3 more
    • Computed Tomography
    • +2 more
    • Birmingham, Alabama
    • +82 more
    Sep 28, 2022

    Early-stage Breast Cancer, Hormone Receptor Positive Breast Carcinoma, Invasive Breast Cancer Trial in United States (drug,

    Recruiting
    • Early-stage Breast Cancer
    • +6 more
    • Fullerton, California
    • +8 more
    Sep 19, 2022

    Tumor Malignant, Renal Cell Carcinoma, Hormone Receptor Positive Breast Carcinoma Trial in Worldwide (XL092, Atezolizumab,

    Recruiting
    • Neoplasm Malignant
    • +5 more
    • Duarte, California
    • +55 more
    Aug 17, 2022

    2nd-line Therapies After CDK4/6i + Hormonal Therapy in HR+/HER2-

    Recruiting
    • Advanced Breast Cancer
    • +2 more
      • Ancona, Italy
      • +28 more
      Jul 27, 2022

      Hormone Receptor Positive Breast Carcinoma, HER2-negative Breast Cancer, PIK3CA Mutant Metastatic Breast Cancer Trial in

      Recruiting
      • Hormone Receptor Positive Breast Carcinoma
      • +2 more
      • Chicago, Illinois
      • +2 more
      Jul 1, 2022

      Tumor Malignant, Epithelial Ovarian Cancer, Triple Negative Breast Cancer Trial in United States (XL102, Fulvestrant,

      Recruiting
      • Neoplasm Malignant
      • +4 more
      • Atlanta, Georgia
      • +4 more
      Apr 19, 2022

      Hormone Receptor Positive Breast Carcinoma, HER2-negative Breast Cancer Trial in Australia, United States (OP-1250)

      Recruiting
      • Hormone Receptor Positive Breast Carcinoma
      • HER2-negative Breast Cancer
      • Orlando, Florida
      • +8 more
      Oct 22, 2021

      Advanced Solid Tumors, Metastatic Colon Cancer, Metastatic Breast Cancer Trial in United States (Fruquintinib (HMPL-013))

      Recruiting
      • Advanced Solid Tumors
      • +6 more
      • Fruquintinib (HMPL-013)
      • Phoenix, Arizona
      • +8 more
      Aug 30, 2021

      Breast Tumor, Hormone Receptor Positive Breast Carcinoma Trial in Orange (Abemaciclib, Fulvestrant)

      Recruiting
      • Breast Neoplasm
      • Hormone Receptor Positive Breast Carcinoma
      • Orange, California
        Chao Family Comprehensive Cancer Center, University of Californi
      Jan 15, 2021